# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-24-102893
Filing Date
2024-04-19
Accepted
2024-04-19 16:14:08
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-19

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | d828561dars.pdf | ARS | 13039833
| Complete submission text file | 0001193125-24-102893.txt |  | 17961791

Mailing Address 501 CANAL BLVD. RICHMOND CA 94084
Business Address 501 CANAL BLVD. RICHMOND CA 94084 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 000-30171 | Film No.: 24857908
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)